Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: A phase II study

  1. Gonzalez, E.E.
  2. Villanueva, N.
  3. Fra, J.
  4. Berros, J.P.
  5. Jimenez, P.
  6. Luque, M.
  7. Muñiz, I.
  8. Blay, P.
  9. Fernandez, Y.
  10. Vieitez, J.M.
  11. Muriel, C.
  12. Sanmamed, M.
  13. Coto, P.P.
  14. Izquierdo, M.
  15. Estrada, E.
  16. Lacave, A.J.
Aldizkaria:
Investigational New Drugs

ISSN: 0167-6997 1573-0646

Argitalpen urtea: 2011

Alea: 29

Zenbakia: 6

Orrialdeak: 1459-1464

Mota: Artikulua

DOI: 10.1007/S10637-010-9442-2 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak